Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

APOE ε4 carrier status modifies plasma p-tau181 concentrations in cognitively healthy super-seniors.

Alzheimer's & dementia : the journal of the Alzheimer's Association - 1 Jun 2024

Cooper Jennifer G, Ghodsi Mohammad, Stukas Sophie, Leach Stephen, Brooks-Wilson Angela, Wellington Cheryl L

Abstract excerpt

INTRODUCTION: This study investigates the effect of apolipoprotein E (APOE) genotype on neurology plasma biomarkers in cognitively healthy Super-Seniors. METHODS: Three hundred seventy plasma specimens from Super-Senior participants ≥ 85 years old, who have never been diagnosed with dementia, cancer, diabetes, cardiovascular, or major pulmonary disease, were analyzed on the Quanterix Simoa HD-X analyzer using...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged, 80 and over
Share to Alzheimer Disease

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Apolipoprotein E4

Share to Biomarkers

Share to Genotype

Share to Heterozygote

Share to Phosphorylation

Share to tau Proteins

Source

Open in PubMed Open full text

Identifiers

PMID: 38752508
DOI: 10.1002/alz.13804
PMCID: PMC11180846

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

APOE ε4 carrier status modifies plasma p-tau181 concentrations in cognitively healthy super-seniors.PMID 38752508Read ↗

Clinical and demographic factors modify the association between plasma phosphorylated tau-181 and cognitionSemantic proximity Read ↗

APOE ε4 carriership status enhances age-related changes in Alzheimer’s disease plasma biomarkers concentrationsSemantic proximity Read ↗

Plasma biomarkers identify older adults at risk of Alzheimer's disease and related dementias in a real‐world population‐based cohortSemantic proximity Read ↗

Don't forget about tau: the effects of ApoE4 genotype on Alzheimer's disease cerebrospinal fluid biomarkers in subjects with mild cognitive impairment-data from the Dementia Competence Network.Semantic proximity Read ↗

Novel Plasma Proteins Associated With Alzheimer’s Disease Risk in APOE ε4 Carriers and Non-carriersSemantic proximity Read ↗

Beyond Lipidation: CSF APOE4 Protein Burden, Not HDL Subclass, Drives Tau Associations in APOE4 Alzheimer’s DiseaseSemantic proximity Read ↗

Plasma proteomics of <i>APOE</i> genotype: age-specific analyses in UK population-based cohortsSemantic proximity Read ↗

Serum proteomics reveals early biomarkers of Alzheimer's disease: The dual role of APOE-ε4Semantic proximity Read ↗

APOE Genotype Modifies the Predictive Performance of Plasma Biomarkers for Amyloid Plaque Burden in Subjective Cognitive Decline.Semantic proximity Read ↗

Proteomic Signatures of Protected <i>APOE</i> -ε4 Carriers Reveal Causal Pathways Associated with Delayed Alzheimer’s Disease OnsetSemantic proximity Read ↗

Serum as an alternative to plasma for determining the ApoE4 phenotype using Pan-ApoE and ApoE4 chemiluminescent enzyme immunoassays.Semantic proximity Read ↗

Association of plasma phosphor-tau181 with Aβ levels may vary by APOE ε4 status and sex among non-demented old adults.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.